| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |